Use of 3-hydroxy fatty acid concentrations in a murine air pouch infection model as a surrogate marker for LPS activity: A feasibility study using environmental Burkholderia cenocepacia isolates

Journal of Microbiological Methods

Volumn 87, Issue 3, 2011, Pages 368-374

  Chen, Yao Shen ^a,b,c   Lin, Hsi Hsun ^b,d   Liu, Pei Ju ^c   Tsai, Hsin Ying ^c   Hsueh, Pei Tan ^c   Liu, Hung Yi ^c   Chen, Ya Lei ^c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

3 Hydroxytetradecanoic acid; Burkholderia cenocepacia; Lipopolysaccharides

Indexed keywords

3 HYDROXY FATTY ACID; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; FATTY ACID; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEASIBILITY STUDY; FEMALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTIONS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL MICROBIOLOGY; FATTY ACIDS; FEASIBILITY STUDIES; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; MURINAE;

EID: 81055157544     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.10.004     Document Type: Article

References (45)

1. Banoub J.H., El Aneed A., Cohen A.M., Joly N. Structural investigation of bacterial lipopolysaccharides by mass spectrometry and tandem mass spectrometry. Mass Spectrom. Rev. 2010, 29:606-650.
2. Beishuizen A., Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J. Endotoxin Res. 2003, 9:3-24.
3. Blackburn L., Brownlee K., Conway S., Denton M. 'Cepacia syndrome' with Burkholderia multivorans, 9years after initial colonization. J. Cyst. Fibros. 2004, 3:133-134.
4. Bønløkke J.H., Mériaux A., Duchaine C., Godbout S., Cormier Y. Seasonal variations in work-related health effects in swine farm workers. Ann. Agric. Environ. Med. 2009, 16:43-52.
5. Bouhafs R.K., Samuelson A., Jarstrand C. Lipid peroxidation of lung surfactant due to reactive oxygen species released from phagocytes stimulated by bacteria from children with cystic fibrosis. Free. Radic. Res. 2003, 37:909-917.
6. Caroff M., Karibian D., Cavaillon J.M., Haeffner-Cavaillon N. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect. 2002, 4:915-926.
7. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., Wang J.M. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 2007, 7:1271-1285.
8. Chen Y.S., Lin H.H., Hung C.C., Mu J.J., Hsiao Y.S., Chen Y.L. Phenotypic characteristics and pathogenic ability across distinct morphotypes of Burkholderia pseudomallei DT. Microbiol. Immunol. 2009, 53:184-189.
9. Chen Y.S., Lin H.H., Mu J.J., Chiang C.S., Chen C.H., Buu L.M., Lin Y.E., Chen Y.L. Distribution of melioidosis cases and viable Burkholderia pseudomallei in soil: evidence for emerging melioidosis in Taiwan. J. Clin. Microbiol. 2010, 48:1432-1434.
10. Chiarini L., Bevivino A., Dalmastri C., Tabacchioni S., Visca P. Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol. 2006, 14:277-286.
11. Cunha F.Q., Assreuy J., Moss D.W., Rees D., Leal L.M., Moncada S., Carrier M., O'Donnell C.A., Liew F.Y. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 1994, 81:211-215.
12. Demanche A., Bonlokke J., Beaulieu M.J., Assayag E., Cormier Y. Swine confinement buildings: effects of airborne particles and settled dust on airway smooth muscles. Ann. Agric. Environ. Med. 2009, 16:233-238.
13. DeSoyza A., Ellis C.D., Khan C.M., Corris P.A., Demarco de Hormaeche R. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am. J. Respir. Crit. Care Med. 2004, 170:70-77.
14. Eaton S., Bartlett K., Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem. J. 1996, 320(Pt 2):345-357.
15. Gangloff S.C., Hijiya N., Haziot A., Goyert S.M. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin. Infect. Dis. 1999, 28:491-496.
16. Jacquot J., Tabary O., Le Rouzic P., Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:1703-1715.
17. Kadurugamuwa J.L., Beveridge T.J. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 1995, 177:3998-4008.
18. Kotzamanidis C., Kourelis A., Litopoulou-Tzanetaki E., Tzanetakis N., Yiangou M. Evaluation of adhesion capacity, cell surface traits and immunomodulatory activity of presumptive probiotic Lactobacillus strains. Int. J. Food Microbiol. 2010, 140:154-163.
19. Kourelis A., Kotzamanidis C., Litopoulou-Tzanetaki E., Papaconstantinou J., Tzanetakis N., Yiangou M. Immunostimulatory activity of potential probiotic yeast strains in the dorsal air pouch system and the gut mucosa. J. Appl. Microbiol. 2010, 109:260-271.
20. Kraśnik L., Szponar B., Walczak M., Larsson L., Gamian A. Routine clinical laboratory tests correspond to increased serum levels of 3-hydroxy fatty acids, markers of endotoxins, in cardiosurgery patients. Arch. Immunol. Ther. Exp. (Warsz.) 2006, 54:55-60.
21. Kuo C.F., Wu J.J., Lin K.Y., Tsai P.J., Lee S.C., Jin Y.T., Lei H.Y., Lin Y.S. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect. Immun. 1998, 66:3931-3935.
22. Li M.H., Luo Y.H., Lin C.F., Chang Y.T., Lu S.L., Kuo C.F., Hong J.S., Lin Y.S. Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group a streptococcal sepsis. Antimicrob. Agents Chemother. 2011, 55:967-973.
23. Lin H.H., Huang S.P., Hsieh H.C., Chen C.S., Chen Y.L. Performance characteristics of the limulus amebocyte lysate assay and gas chromatography-mass spectrum analysis of lipopolysaccharides relative to nitric oxide production by peritoneal exudates of cells. J. Hazard. Mater. 2007, 145:431-436.
24. Loutet S.A., Flannagan R.S., Kooi C., Sokol P.A., Valvano M.A. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J. Bacteriol. 2006, 188:2073-2080.
25. McKenzie J.H., Alwis K.U., Sordillo J.E., Kalluri K.S., Milton D.K. Evaluation of lot-to-lot repeatability and effect of assay media choice in the recombinant factor C assay. J. Environ. Monit. 2011, 13:1739-1745.
26. Nichols D., Chmiel J., Berger M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin. Rev. Allergy Immunol. 2008, 34:146-162.
27. Park J.H., Gold D.R., Spiegelman D.L., Burge H.A., Milton D.K. House dust endotoxin and wheeze in the first year of life. Am. J. Respir. Crit. Care Med. 2001, 163:322-328.
28. Park J.H., Szponar B., Larsson L., Gold D.R., Milton D.K. Characterization of lipopolysaccharides present in settled house dust. Appl. Environ. Microbiol. 2004, 70:262-267.
29. Park B.S., Song D.H., Kim H.M., Choi B.S., Lee H., Lee J.O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458:1191-1195.
30. Pomorska D., Larsson L., Skórska C., Sitkowska J., Dutkiewicz J. Levels of bacterial endotoxin in air of animal houses determined with the use of gas chromatography-mass spectrometry and Limulus test. Ann. Agric. Environ. Med. 2007, 14:291-298.
31. Ramette A., LiPuma J.J., Tiedje J.M. Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl. Environ. Microbiol. 2005, 71:1193-1201.
32. Reynolds S.J., Milton D.K., Heederik D., Thorne P.S., Donham K.J., Croteau E.A., Kelly K.M., Douwes J., Lewis D., Whitmer M., Connaughton I., Koch S., Malmberg P., Larsson B.M., Deddens J., Saraf A., Larsson J. Interlaboratory evaluation of endotoxin analyses in agricultural dusts-comparison of LAL assay and mass spectrometry. J. Environ. Monit. 2005, 7:1371-1377.
33. Rund S., Lindner B., Brade H., Holst O. Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2. J. Biol. Chem. 1999, 274:16819-16824.
34. Sajjan U., Ackerley C., Forstner J. Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium. Cell. Microbiol. 2002, 4:73-86.
35. Saldías M.S., Valvano M.A. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 2009, 155:2809-2817.
36. Saraf A., Larsson L., Burge H., Milton D. Quantification of ergosterol and 3-hydroxy fatty acids in settled house dust by gas chromatography-mass spectrometry: comparison with fungal culture and determination of endotoxin by a Limulus amebocyte lysate assay. Appl. Environ. Microbiol. 1997, 63:2554-2559.
37. Sebastian A., Pehrson C., Larsson L. Elevated concentrations of endotoxin in indoor air due to cigarette smoking. J. Environ. Monit. 2006, 8:519-522.
38. Silipo A., Molinaro A., Ieranò T., De Soyza A., Sturiale L., Garozzo D., Aldridge C., Corris P.A., Khan C.M., Lanzetta R., Parrilli M. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). Chemistry 2007, 13:3501-3511.
39. Simpson A., John S.L., Jury F., Niven R., Woodcock A., Ollier W.E., Custovic A. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am. J. Respir. Crit. Care Med. 2006, 174:386-392.
40. Szponar B., Kraśnik L., Hryniewiecki T., Gamian A., Larsson L. Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin. Chem. 2003, 49:1149-1153.
41. Urban T.A., Griffith A., Torok A.M., Smolkin M.E., Burns J.L., Goldberg J.B. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect. Immun. 2004, 72:5126-5134.
42. Vinion-Dubiel A.D., Spilker T., Dean C.R., Monteil H., LiPuma J.J., Goldberg J.B. Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex. J. Clin. Microbiol. 2004, 42:4121-4126.
43. Watts J.A., Kline J.A., Thornton L.R., Grattan R.M., Brar S.S. Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J. Mol. Cell. Cardiol. 2004, 36:141-150.
44. Zhao Z., Sebastian A., Larsson L., Wang Z., Zhang Z., Norbäck D. Asthmatic symptoms among pupils in relation to microbial dust exposure in schools in Taiyuan. China Pediatr. Allergy Immunol. 2008, 19:455-465.
45. Zughaier S.M., Ryley H.C., Jackson S.K. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun. 1999, 67:1505-1507.